Recent changes in prostate cancer mortality in Chile. Trends analysis from 1955 to 2001;Cambios recientes en la mortalidad por cáncer de próstata en Chile: Estudio de tendencias en el período 1955-2001

Revista Medica de Chile

Volumn 132, Issue 5, 2004, Pages 579-587

  Vives V, Alejandra ^a,b   Valdivia C, Gonzalo ^a   Marshall R, Guillermo ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b Santiago Centro   (Chile)

Author keywords

Mortality; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

ARTICLE; CANCER MORTALITY; CHILE; HUMAN; MORTALITY; PROSTATE CANCER; REGRESSION ANALYSIS;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; POISSON DISTRIBUTION; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS;

EID: 12544256756     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. OLIVER S, MAY M, GUNNEL D. International trends in prostate-cancer mortality in the "PSA era". Int J Cancer 2001; 92: 893-8.
2. HSING A, TSAO L, DEVESA S. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer (Pred Oncol) 2000; 85: 60-7.
3. Anuario de Estadísticas Vitales 2000. Instituto Nacional de Estadísticas.
4. Departamento de Estadísticas e Información de Salud - Ministerio de Salud, Chile. Causas de muerte, 1999. http://deis.minsal.cl/deis/ vitales/pais/chi_80ym.htm.
5. MINSAL, Octubre 2002. Los objetivos sanitarios para la década 2000-2010.
6. Plan de Acceso Universal con Garantías Explícitas (AUGE): Construcción de la propuesta técnica del Plan de Salud de las Person as Año Base. Tomo I: Descripción de la Propuesta Técnica, Junio 2002.
7. Surveillance, Epidemiology and End Results (SEER) Program, Prostate Cancer, Trends in Incidence and Mortality by Race and Age 1975-2000.
8. MARTÍNEZ L. Evaluación longitudinal y predicción de tasas de defunción por cáncer prostático en Chile. Rev Chil Urol 1995; 60: 56-9.
9. Instituto Nacional de Estadísticas. Censo 2002. Versión 1.0.2.
10. WATERHOUSE J, MUIR C, CORREA P, POWELL J. Cancer incidence in Five Continents, Vol III. IARC Scientific Publications No 15. Lyon, 1976.
11. Joinpoint Regression Program, Versión 2.7. Septiembre 2003; National Cancer Institute. Bethesda, EEUU.
12. KIM H-J, FAY M, FEUER E, MIDTHUNE D. Permutation tests for joinpoint regression with applications to cancer rates. Statist Med 2000; 19: 335-51.
13. CORTI D, FONERÓN A, TRONCOSO L, EBEL L, MARCHETTI P, MUÑOZ N. Epidemiología del cáncer de próstata. Provincia de Valdivia, 1990-2000. Rev Chil Urol 2002; 67: 211-4.
14. Anuarios de Egresos Hospitalarios, Instituto Nacional de Estadísticas. 1970, 1971, 1973, 1975, 1981-1989.
15. POTOSKY A, FEUER E, LEVIN D. Impact of screening on incidence and mortality of prostate cancer in the United States. Epidemiol Rev 2001; 23: 181-6.
16. OLIVER S, GUNNEL D, DONOVAN J. Comparison of trends in prostate cancer mortality in England and Wales and the USA. The Lancet 2000; 355: 1788-9.
17. MEYER F, MOORE L, BAIRATI I, FRADET Y. Downward trend in prostate cancer mortality in Quebec and Canada. J Urol 1999; 161: 1189-91.
18. HSING A, DEVESA S. Trends and patterns of prostate cancer: What do they suggest? Epidemiol Rev 2001; 23: 3-13.
19. FEUER E, MERRILL R, HANKEY B. Cancer surveillance series: interpreting trends in prostate cancer-part II: cause of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst 1999; 91: 1025-32.
20. SZKLO M, NIETO J. Epidemiology. Beyond the Basics. Maryland: Aspen Publishers, Inc. 2000; 8-16.
21. HANKEY B, FEUER E, CLEGG L, LEGLER J, RIES L, HAYES R ET AL. Cancer surveillance series: interpreting trends in prostate cancer-Part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality and survival rates. J Natl Cancer Inst 1999; 91: 1017-24.
22. QUINN M, BABB P. Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons. BJU Int 2002; 90: 162-73.
23. LEVY I, GIBBONS L, COLLINS J, PERKINS D, MAO Y. Prostate cancer trends in Canada: rising incidence or increased detection? JAMC 1993; 149: 617-24.
24. METTLIN C. The meaning of prostate cancer trends. Journal of Pelvic Surgery 2001; 7: 358-60.
25. COLDMAN A, PHILLIPS N, PICKLES T. Trends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity. CMAJ 2003; 168: 31-5.
26. LU-YAO G, ALBERTSEN P, STANFORD J, STUKEL T, WALKER-CORKERY E, BARRY M. Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. BMJ 2002; 325: 740-3.
27. BARTSCH G, HORNIGER W, KLOCKER H, REISSIGL A, OBERAIGNER W, SCHÖNITZER D ET AL. Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria. Urology 2001; 58: 417-24.
28. COORY M, BAADE P. Mortality from prostate cancer is decreasing. MJA 2002; 176: 354-5.
29. HARRIS R, LOHR K. Screening for prostate cancer: an update of the evidence for the US preventive services task force. Ann Intern Med 2002; 137: 917-29.
30. WILSON AND JUNGHER, 1968 en The Public Health Bush Book, Departament of Health and Community Services, Northen Territory Govermment, Australia 2002.
31. US Preventive Services Task Force. Screening for Prostate Cancer: Recommendation and Rationale. Ann Intern Med 2002; 137: 915-6.
32. Guideline for use of PSA and screening for prostate cancer. The Alberta Clinical Practice Guidelines Program. Junio, 1997.
33. Psa Best Practice Policy Task Force, American Urological Association. Prostate-Specific Antigen (PSA) Best Practice Policy. Oncology 2000; 14: 267-86.
34. American College of Physicians. Clinical Guideline, Part III: Screening for Prostate Cancer. Ann Intern Med 1997; 126: 480-4.
35. QUAGLIA A, PARODI S, GROSCLAUDE P, MARTÍNEZ-GARCÍA C, COEBERGH JW, VERCELLI M. Differences in the epidemic rise and decrease of prostate cancer among geographical areas in Southern Europe: an analysis of differential trends in incidence and mortality in France, Italy and Spain. Eur J Cancer 2003; 39: 654-65.